1 Kramer P, Wigger W, Reiger J, et al. Arteriovenous haemofiltration: a new and simple method for treatment of overhydrated patients resistant to diuretics [J]. Klin Wochenschr, 1977, 55:1121–2 (in German).
2 Ronco C, Bellomo R. Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs, 2002, 25(8):733–747.
3 Husain-Syed F, Ricci Z, Brodie D, et al. Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk. Intensive Care Med, 2018, 44(9):1447–1459.
4 Ronco C, Ricci Z, Husain-Syed F. From multiple organ support therapy to extracorporeal organ support in critically ill patients. Blood Purif, 2019, 48(2):99–105.
5 Vincent JL, Mendon?a A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis related problems” of the European society of intensive care medicine. Crit Care Med, 1998, 26(11):1793–1800.
6 Ranieri VM, Brodie D, Vincent JL, et al. Extracorporeal organ support: from technological tool to clinical strategy supporting severe organ failure. JAMA, 2017, 318(12):1105–1106.
7 Gottschalk CW, Fellner SK. History of the science of dialysis. Am J Nephrol, 1997, 17(3–4):289–298.
8 Twardowski ZJ. History of hemodialyzers designs. Hemo dial Int, 2008, 12(2):173–210.
9 Boettcher W, Merkle F, Weitkemper HH, et al. History of extracorporeal circulation: the conceptional and developmental period. J Extra Corpor Technol, 2003, 35(3):172–183.
10 Kolobow T, Bowman RL. Construction and evaluation of an alveolar membrane artificial heart-lung. Trans Am Soc Artif Intern Organs, 1963, 9:238–243.
11 Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA, 2005, 294(7):813–818.
12 Ronco C, 张凌，陆任华，等. 重症肾脏替代治疗和血液净化技术的标准化术语命名 [J]. 华西医学杂志, 2018, 33（7）：782-796
13 Combes, Fanelli V, Tai Pham T, et al. Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med, 2019, 45(5):592–600.
14 Passaroni AC, Silva MA, Yoshida WB, et al. Cardiopulmonary bypass: development of John Gibbon’s heart-lung machine. Rev Bras Cir Cardiovasc, 2015, 30(2):235–245.
15 Zapol WM, Snider MT, Donald Hill J, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA, 1979, 242(20):2193–2196.
16 Combes A, Slutsky AS, Brodie D, et al. ECMO for severe acute respiratory distress syndrome. N Engl J Med, 2018, 379(11):1091–1092.
17 Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multi-center randomized controlled trial. Lancet, 2009, 374(9698):1351–1363.
18 Gattinoni L, Pesenti A, Mascheroni D, et al. Low-frequency positive pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA, 1996, 256(7):881–886.
19 Bein T, Weber-Carstens S, Goldmann A, et al. Lower tidal volume strategy (approximately 3ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation(6ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med, 2013, 39(5):847–856.
20 Zanella A, Castagna L, Salerno D, et al. Respiratory electrodialysis. A novel, highly efficient extracorporeal CO2 removal technique. Am J Respir Crit Care Med, 2015, 192(6):719–726.
21 Kreymann B, Seige M, Schweigart U, et al. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol, 1999, 31(6):1080–1085.
22 Stange J, Mitzner SR, Risler T, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane based blood purification system for bioartificial liver support. Artif Organs, 1999;23:319–30.
23 Banares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating systemin acute-on-chronic liver failure: the RELIEF trial. Hepatology, 2013, 57(3):1153–1162.
24 Gerth HU, Pohlen M, Th?lking G ,et al (2017) Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure—a retrospective analysis. Crit Care Med,2017, 45(10):1616–1624.
25 Kribben A, Gerken G, Haag S, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology, 2012, 142(4):782–789.e3.
26 Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomized controlled trial. J Hepatol, 2016, 64(1):69–78.
27 He YT, Qi YN, Zhang BQ, et al. Bioartificial liver support systems for acute liver failure: a systematic review and meta-analysis of the clinical and preclinical literature. World J Gastroenterol, 2019, 25(27):3634–3648.
28 Thompson J, Jones N, Al-Khafaji A, et al. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial. Liver Transpl, 2018, 24(3):380–393.
29 Ruiz de Garbay AP, Kellum JA, Honigschnabel J, et al. Respiratory and metabolic acidosis correction with the ADVanced organ support system. Intensive Care Med Exp, 2019, 7(1):56.
30 Yamasaki K, Maruyama T, Yoshimoto K, et al. Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. Biochim Biophys Acta, 1999, 1432(2):313–323.
31 Fujii T, Ganeko R, Kataoka Y, et al. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis [J]. Intensive Care Med, 2018, 44:167–78.
32 Klein DJ, Foster D, Walker PM, et al. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial [J]. Intensive Care Med, 2018, 44:2205–12.
33 Schadler D, Pausch C, Heise D, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial [J]. PLoS ONE, 2017, 12:e0187015.
34 Zuccari S, Damiani E, Domizi R, et al. Changes in cytokines, haemodynamics and microcirculation in patients with sepsis/septic shock undergoing continuous renal replacement therapy and blood purification with CytoSorb [J]. Blood Purif, 2020, 49:107–113.
35 Haase M, Silvester W, Uchino S, et al. A pilot study of high-adsorption hemofiltration in human septic shock [J]. Int J Artif Organs, 2007, 30:108–17.
36 Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices [J]. Intensive Care Med Exp, 2018, 6(1):12.
37 Shiga H, Hirasawa H, Nishida O, et al. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report [J]. Blood Purif, 2014, 38:211–8.
38 Schwindenhammer V, Girardot T, Chaulier K, et al. oXiris? use in septic shock: Experience of two French centres [J]. Blood Purif, 2019, 47(suppl 3):1–7.
39 Lahmer T, Mayr U, Rasch S, et al. In-parallel connected intermittent hemodialysis through ECMO does not affect hemodynamic parameters derived from transpulmonary thermodilution. Perfusion，2017, 32(8):702–705.
40 Herner A, Lahmer T, Mayr U, et al. Transpulmonary thermodilution before and during veno-venous extracorporeal membrane oxygenation ECMO: an observational study on a potential loss of indicator into the extra-corporeal circuit. J Clin Monit Comput, 2019. https://doi.org/10.1007/s10877-019-
